| Primary information |
|---|
| sequence ID | Seq_7541 |
| Peptide sequence | SQLQKVPPEWK |
| CancerPDF_ID | CancerPDF_ID675, CancerPDF_ID2299, CancerPDF_ID10087, |
| PMID | 19795908,21136997,21805675 |
| Protein Name | Fibrinogen alpha chain,Fibrinogen alpha,Fibrinogen alpha chain |
| UniprotKB Entry Name | FIBA_HUMAN,FIBA_HUMAN,FIBA_HUMAN |
| Fluid | Plasma,Plasma,Urine |
| M/Z | "670.36, 447.24",1338.7296,1339.7507 |
| Charge | "2, 3",1,NA |
| Mass (in Da) | NA,NA,NA |
| fdr | NA,NA,NA |
| Profiling Technique | LC-MS,LC-MS,MALDI-TOF |
| Peptide Identification technique | MALDI-TOF/TOF,LC-MS-MS/MS,MALDI-TOF-MS |
| Quantification Technique | LC-MRM (multiple reaction monitoring),LC-ESI-MS,NA |
| Labelled/Label Free | Labelled,Label Free,Label Free |
| FDR | less than 7%,NA,1 |
| CancerPDF_ID | CancerPDF_ID675, CancerPDF_ID2299, CancerPDF_ID10087, |
| p-Value | NA,NA,NA |
| Software | FlexAnalysis 3.0 and Biotools 3.0 software,MASCOT(v. 2.2.01),NA |
| Length | 11,11,11 |
| Cancer Type | Ductal adenocarcinoma of the pancreas (DAP),Normal,Muscle-invasive bladder cancer |
| Database | NCBI refseq Protein Database,SwissProt Database,SwissProt Database |
| Modification | NA,NA,NA |
| Number of Patients | "42 normal, 28patients",27 healthy individuals,751 bladder cancer and 127 control |
| Regulation | NA,NA,Differentially expressed between cancer vs normal samples |
| Validation | NA,Leave One out Cross validation,Mann-Whitney tests and areas under receiver-operator characteristic |
| Sensitivity | NA,NA,NA |
| Specificity | NA,NA,NA |
| Accuracy | NA,NA,NA |
| Peptide Atlas | PeptideAtlas |
| IEDB | |